Advocate
Resource hub for campaigns, advocacy materials, and tools developed by hepCoalition and partner organizations that can be adapted and used by advocates for local campaigns in their own contexts.
Campaigns
Campaigns include the ongoing efforts that aim to expand affordable treatment and diagnostics access for all who need it.
Liberate Generics!
Ongoing, global campaign working to accelerate equitable access to affordable, generic hepatitis C treatments. More
- About the campaign
- Gilead’s License on Hepatitis C Drugs, Sofosbuvir and Ledipasvir: a Fool’s Bargain
- Doctors of the World Opposes the Patent on Sofosbuvir
- APN+ Joins MTAAG+ in Congratulating Malaysia on Sofosbuvir Compulsory License
- Hepatitis C Cure, Sofosbuvir, Turns 5 Years Old: The Vast Majority of People Still Nave Not Been Treated
- Activists Demand Affordable Hepatitis C Treatment
- First Hepatitis C Treatment Developed Through South-South Cooperation Registered in Malaysia
- Gilead’s Claim That Generic Purchase of Sofosbuvir Would Lead to Patent Infringement in Brazil Dismissed
- Sofosbuvir Case in Brazil
Have a Heart, Save My Liver!
Ongoing, global campaign focusing on where the registration of diagnostics and direct-acting antivirals has stalled as well as the slow treatment uptake in low- and middle-income countries. More
- About the campaign
- Have a Heart, Save My Liver!: Where Are My Diagnostics?
- Who Has Access to Hepatitis C Testing? Liberate Our Diagnostics!
- Access to Hepatitis C Treatment and Care Among People Who Inject Drugs: Failing People Most Disproportionately Affected
- Have a Heart, Save My Liver! Where is the Cure Registered?
- Have A Heart, Save My Liver! Which Countries Restrict Treatment?
Take Action!
The section includes sign-on letters, petitions, and collective statements.
Advocates Demand Continuous Catalytic Investment Towards Viral Hepatitis Elimination
An open letter sent to Unitaid demands continuous investment towards HBV and HCV elimination, and to address the needs of 354 million people living with viral hepatitis worldwide. More
#FreeChangsha3: Wrongfully Detained HIV/Viral Hepatitis Activists
Three Chinese lawyers and advocates, who work on employment discrimination and disability justice for people living with HIV and viral hepatitis, have been wrongfully detained in China. More
Advocacy Tools
Advocacy materials and tools developed by hepCoalition and partner organizations that can be adapted and used by advocates for local campaigns in their own contexts. Includes training materials, community monitoring/data collection, and graphics.
Hepatitis C and TB Long-Acting Medicines: Analysis of Patenting Trends and Implications for Access
A patent landscape, released by TAG, investigates potential patent barriers for the development and delivery of long-acting formulations for selected hepatitis C and TB medicines. More
Have A Heart, Save My Liver! Which Countries Restrict Treatment?
A fact sheet, developed by the hepCoalition, provides in-country data about HCV treatment rationing through different forms of restrictions. More
Policy Statements
The section includes partners’ policy and advocacy statements that can aid activists in their messaging and calls to action.
EASL Policy Statement: Drug Use and the Global Hepatitis C Elimination Goal
EASL made a bold policy statement, based on a science-based policy brief, to lift treatment barriers and decriminalize drug use as part of elimination strategies. More
African Declaration to Eliminate Hepatitis C and Improve the Health of People Who Use Drugs
Cape Town, South Africa, 20 February 2020
People working to eliminate hepatitis C in the African region express alarm regarding the increasing impact of drug use, hepatitis C, and other viral co-infections on the well-being of PWUD. More
